Zobrazeno 1 - 10
of 11
pro vyhledávání: '"James C. Kisicki"'
Publikováno v:
American Journal of Therapeutics. 18:2-8
Morphine sulfate and naltrexone hydrochloride extended release capsules (EMBEDA®, King Pharmaceuticals®, Inc., Bristol, TN), indicated for the management of chronic, moderate to severe pain, contain extended release morphine pellets with a sequeste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a21bd47dc697428da19a5028008782c5
https://doi.org/10.1097/mjt.0b013e3181f05957
https://doi.org/10.1097/mjt.0b013e3181f05957
Publikováno v:
Pharmacotherapy. 27:963-969
Study objective To evaluate the effect of an aluminum- and magnesium-containing antacid (Al-Mg antacid), which contains a high concentration of cations, on the pharmacokinetics of garenoxacin. Design Prospective, randomized, open-label, control-balan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c045c77bbb04288e8f2dfdb254c8a598
https://doi.org/10.1592/phco.27.7.963
https://doi.org/10.1592/phco.27.7.963
Publikováno v:
Journal of Pain and Symptom Management. 26:743-747
It is unknown whether two smaller doses of oral transmucosal fentanyl citrate (OTFC) administered simultaneously are pharmacokinetically equivalent to an identical dose administered as a single unit. This issue has important practical implications wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dcf41d13e08df5560cc0fdcb240d9c2
https://doi.org/10.1016/s0885-3924(03)00241-0
https://doi.org/10.1016/s0885-3924(03)00241-0
Autor:
David C. Korts, Paul Koker, Louis Diamond, Martin Posner, James C. Kisicki, Miguel A. Zinny, Dockhorn Rj, J Grossman, Margaret T. Wecker
Publikováno v:
Journal of Allergy and Clinical Immunology. 95:1139-1146
Rhinorrhea is an annoying symptom of the common cold for which effective therapy is not currently available. Ipratropium bromide (IB) is an anticholinergic drug that has been shown to decrease glandular secretion when applied topically to the nasal m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3306eb6db2b8110521dcf0194855a5c3
https://doi.org/10.1016/s0091-6749(95)70219-9
https://doi.org/10.1016/s0091-6749(95)70219-9
Publikováno v:
Clinical therapeutics. 29(9)
Background: Guanfacine hydrochloride is an α 2a -adrenoreceptor agonist found to be effective in the treatment of attention-deficit/hyperactivity disorder (ADHD). Because the available immediate-release formulation requires multiple daily dosing and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4244cc00abac3c061fb291a7dab4dd8f
https://pubmed.ncbi.nlm.nih.gov/18035196
https://pubmed.ncbi.nlm.nih.gov/18035196
Publikováno v:
The Annals of pharmacotherapy. 36(3)
OBJECTIVE:To assess potential interactions of colesevelam hydrochloride and lovastatin in healthy volunteers when lovastatin alone was administered with dinner, both lovastatin and colesevelam were administered with dinner, and colesevelam was admini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dd62a744028f37ad572205e70de273f
https://pubmed.ncbi.nlm.nih.gov/11895049
https://pubmed.ncbi.nlm.nih.gov/11895049
Autor:
Wayne A. Colburn, Robert J. Przybelski, James C. Kisicki, Elaine K. Daily, Marilyn J. Bounds, Cynthia Mattia-Goldberg
Publikováno v:
Critical care medicine. 24(12)
Objective To evaluate the safety, pharmacokinetics, and pharmacodynamics of diaspirin cross-linked hemoglobin solution (DCLHb[TM]) in normal, healthy volunteers. Design Randomized, double-blind, controlled, crossover study. Setting Phase I research f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bcfe5293aa37e95f53efb17a7ab5d81
https://pubmed.ncbi.nlm.nih.gov/8968267
https://pubmed.ncbi.nlm.nih.gov/8968267
Autor:
Bruce P. Ekholm, Kim A. Lavoie, Lester I. Harrison, Shaw F. Chang, Colin R. Kehe, James C. Kisicki
Publikováno v:
Journal of pharmaceutical sciences. 83(8)
The objective of this study was to determine if the theophylline diurnal variation that has been observed primarily between morning and evening doses of twice-a-day products could be overcome by a once-a-day formulation. Eighteen healthy, nonsmoking,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc72523a0236f2c15b6e9aaf01f1c4d
https://pubmed.ncbi.nlm.nih.gov/7983603
https://pubmed.ncbi.nlm.nih.gov/7983603
Autor:
Sally E. Mccarville, Nancy M. Klinger, Karen A. Wick, Shaw F. Chang, Amit K. Mitra, James C. Kisicki, Dockhorn Rj, Steve M. Berge, Colin R. Kehe, Kathy M. Cooper, Lester I. Harrison, Patrick J. Roddy
Publikováno v:
Journal of pharmaceutical sciences. 82(6)
Two three-way crossover studies were done to characterize the drug release characteristics of Monospan (3M Pharmaceuticals, St. Paul, MN) capsules, a new once-a-day theophylline formulation. In the first study, 22 healthy males received single 450-mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efd8607a65c411207aa393d45fbd8525
https://pubmed.ncbi.nlm.nih.gov/8331541
https://pubmed.ncbi.nlm.nih.gov/8331541
Autor:
Jon L. Ruckle, Chris Sinclair, Thomas Marbury, Dennis Swearingen, Maurice Genereux, William Brooks, James C. Kisicki
Publikováno v:
Blood. 106:3988-3988
WinRho® SDF is licensed in the USA, Canada and Europe to treat ITP and prevent Rh isoimmunization. Although safe, efficacious and cost-effective, WinRho® SDF has only been available in a freeze-dried formulation. In order to simplify injection prep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77f2edeab9b1ff63495cd1cddeb62052
https://doi.org/10.1182/blood.v106.11.3988.3988
https://doi.org/10.1182/blood.v106.11.3988.3988